---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-188930"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2023-07-18T23:59:59+00:00"
generated_at: "2026-06-13T06:51:27.180503+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma rejects activist consent solicitation to remove board without cause under Delaware law

## Summary
- Anson Advisors and Cable Car Capital launched consent solicitation on July 17, 2023 to remove all directors without cause and repeal recent bylaw amendments.
- MEI states removal proposal is invalid under Delaware law because classified board directors may only be removed for cause; charter does not provide otherwise.
- Bylaw proposal is unnecessary as no bylaw amendments have been made since February 23, 2023, and board has no current intent to amend.
- Board urges shareholders to vote FOR the pending Infinity Pharmaceuticals merger, endorsed by ISS and Glass Lewis.
- Company reserves the right to contest any solicitation or actions taken in connection with the invalid proposals.

## SEC filing metadata
- accession: 0001193125-23-188930
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2023-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000119312523188930/0001193125-23-188930-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000119312523188930/d531811d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-188930
- JSON: https://secwatch.observer/filing/0001193125-23-188930.json
- Plain text: https://secwatch.observer/filing/0001193125-23-188930.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.